1. HBW Insight
  3. >>Policy & Regulation

FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements

 
• By Malcolm Spicer

FDA announces addition of Dietary Supplement Ingredient Advisory List page to its website to identify ingredients it has preliminary determined should be used in dietary supplements. It also publishes warning letters submitted recently to firms marketing supplements containing two ingredients agency has concluded should not be used: eight were warned about using an ingredient identified as "DMHA" and three about using phenibut.

The US Food and Drug Administration delivers on its plan for a "rapid response tool" to identify and publish ingredients the agency says could be ineligible for use in dietary supplements. The tool doesn't, however, deliver brand names or identify firms marketing products containing the ingredients.

The FDA announced the addition of the Dietary Supplement Ingredient Advisory List to its website on April 16 with four ingredients – andarine, higenamine, hordenine and 1,4-DMAA– that the agency has preliminarily determined should not be used vitamin, minerla or supplement products because they are not dietary ingredients or are new dietary ingredients that have not been notified to the agency with proof of a reasonable expectation of safety for their intended use

Additionally, the FDA published warning letters submitted recently to firms marketing supplements containing two ingredients that the agency has concluded should not be used in VMS products: eight were warned about using an ingredient identified as

More from Regulation

More from Policy & Regulation

Third-Party ‘Testing, Inspection and Certification’ Cleaning Up Amazon Supplement Market

 
• By Malcolm Spicer

Three FDA warnings related to supplement manufacturing, labeling or marketing submitted to Amazon or companies selling vitamin, mineral or supplement products on its e-commerce platform since April 2024.

Digital Services Deliver Hemp, States Deliver Regulation With Congress Yet To Act

 
• By Malcolm Spicer

Four months into session, no bills have been introduced in Congress to authorize FDA to establish a regulatory pathway for the lawful use of hemp ingredients in products other than drugs or propose some other solution to the federal conundrum present since lawmakers in 2018 de-scheduled hemp.

Little Industry Opposition To FDA Plan To Remove Synthetic Dyes, Or Agreement They’re Unsafe

 
• By Malcolm Spicer

Dyes and colors which FDA says industries agree should no longer be used aren’t unsafe and are currently used only with the agency’s approval, industry stakeholders say. Center for Science in the Public Interest says the dyes are used “in tens of thousands of foods and beverages that are commonly consumed here in the United States.”